Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Oncol (R Coll Radiol) ; 23(4): 276-81, 2011 May.
Article in English | MEDLINE | ID: mdl-21345659

ABSTRACT

The only unequivocal radiological effect of the Chernobyl accident on human health is the increase in thyroid cancer in those exposed in childhood or early adolescence. In response to the scientific interest in studying the molecular biology of thyroid cancer after Chernobyl, the Chernobyl Tissue Bank was established. The project is supported by the governments of Ukraine and Russia, and financially supported (in total around US$3 million) by the European Commission, the National Cancer Institute of the USA and the Sasakawa Memorial Health Foundation of Japan. The project began collecting a variety of biological samples from patients on 1 October 1988, and has supplied material to 21 research projects in Japan, the USA and Europe. The establishment of the Chernobyl Tissue Bank has facilitated co-operation between these research projects and the combination of clinical and research data provides a paradigm for cancer research in the molecular biological age.


Subject(s)
Chernobyl Nuclear Accident , Neoplasms, Radiation-Induced/pathology , Thyroid Neoplasms/pathology , Tissue Banks , Data Collection , Female , Humans , Male , Neoplasms, Radiation-Induced/blood , Neoplasms, Radiation-Induced/etiology , Radioactive Hazard Release , Thyroid Neoplasms/blood , Thyroid Neoplasms/etiology , Ukraine
2.
Eur J Biochem ; 182(1): 1-9, 1989 Jun 01.
Article in English | MEDLINE | ID: mdl-2543569

ABSTRACT

Exposure of the temperature-sensitive leucyl-tRNA synthetase mutant of Chinese hamster ovary cells, tsH1, to the non-permissive temperature of 39.5 degrees C results in a rapid inhibition of polypeptide chain initiation. This inhibition is caused by a reduced ability of the eukaryotic initiation factor eIF-2 to participate in the formation of eIF-2.GTP.Met-tRNAf ternary complexes and thus in the formation of 43S ribosomal pre-initiation complexes. Associated with this decreased eIF-2 activity is an increased phosphorylation of the eIF-2 alpha subunit. It has previously been shown in other systems that phosphorylation of eIF-2 alpha slows the rate of recycling of eIF-2.GDP to eIF-2.GTP catalysed by the guanine nucleotide exchange factor eIF-2B. We show here that phosphorylation of eIF-2 alpha by the reticulocyte haem-controlled repressor also inhibits eIF-2B activity in cell-free extracts derived from tsH1 cells. Thus the observed increased phosphorylation of eIF-2 alpha at the non-permissive temperature in this system is consistent with impaired recycling of eIF-2 in vivo. Using a single-step temperature revertant of tsH1 cells, TR-3 (which has normal leucyl-tRNA synthetase activity at 39.5 degrees C), we demonstrate here that all inhibition of eIF-2 function reverts together with the synthetase mutation. This establishes the close link between synthetase function and eIF-2 activity. In contrast, recharging tRNALeu in vivo in tsH1 cells at 39.5 degrees C by treatment with a low concentration of cycloheximide failed to reverse the inhibition of eIF-2 function. This indicates that tRNA charging per se is not involved in the regulatory mechanism. Our data indicate a novel role for aminoacyl-tRNA synthetases in the regulation of eIF-2 function mediated through phosphorylation of the alpha subunit of this factor. However, in spite of the fact that cell-free extracts from Chinese hamster ovary cells contain protein kinase and phosphatase activities active against either exogenous or endogenous eIF-2 alpha, we have been unable to show any activation of kinase or inactivation of phosphatase following incubation of the cells at 39.5 degrees C.


Subject(s)
Amino Acyl-tRNA Synthetases/metabolism , Peptide Initiation Factors/metabolism , Protein Biosynthesis , Proteins/metabolism , Amino Acyl-tRNA Synthetases/antagonists & inhibitors , Amino Acyl-tRNA Synthetases/genetics , Animals , Cell Line , Cell-Free System , Cricetinae , Cycloheximide/pharmacology , Eukaryotic Initiation Factor-2 , Mutation , Phosphoric Monoester Hydrolases/metabolism , Protein Kinases/metabolism , RNA, Transfer, Leu/metabolism , Temperature , eIF-2 Kinase
3.
Nucleic Acids Res ; 16(8): 3497-510, 1988 Apr 25.
Article in English | MEDLINE | ID: mdl-2897658

ABSTRACT

Polyadenylated mRNA has been purified from a variety of human and mouse cell sources. These preparations are actively translated in the wheat germ cell-free system but have only poor ability to stimulate the nuclease-treated reticulocyte lysate. The translation of endogenous and exogenous globin mRNA is strongly inhibited by the poly(A)+ RNA preparations in reticulocyte lysates. Both polysomal and non-polysomal RNA have similar effects but poly(A)+ RNA is almost 2000-fold more inhibitory than poly(A)-RNA on a weight basis. The inhibition is abolished in the presence a high concentration of poly(I).poly(C). Analysis of endogenous eIF-2 in the lysate reveals that the subunit becomes extensively phosphorylated in the presence of the inhibitory poly(A)+ RNA. Prolonged incubation of lysate with poly(A)+ RNA also causes some nucleolytic degradation of polysomal globin mRNA. These characteristics suggest that some eukaryotic cell mRNAs contain regions of double-stranded structure which are sufficiently extensive to activate translational control mechanisms in the reticulocyte lysate.


Subject(s)
Gene Expression Regulation/drug effects , Poly A/pharmacology , Protein Biosynthesis/drug effects , RNA, Messenger/pharmacology , Animals , Cell-Free System , Depression, Chemical , Enzyme Activation/drug effects , Eukaryotic Initiation Factor-2 , Globins/genetics , Humans , Mice , Nucleic Acid Conformation , Peptide Initiation Factors/metabolism , Poly A/antagonists & inhibitors , Poly A/metabolism , Poly I-C/pharmacology , Proteins/metabolism , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/metabolism , RNA, Neoplasm/metabolism , Rabbits , Reticulocytes , Triticum , Tumor Cells, Cultured
4.
J Biol Chem ; 262(2): 767-71, 1987 Jan 15.
Article in English | MEDLINE | ID: mdl-3805006

ABSTRACT

When cultures of the temperature-sensitive Chinese hamster ovary cell mutant tsH1 are shifted from 34 degrees C (permissive temperature) to 39.5 degrees C (nonpermissive temperature), protein synthesis is inhibited by more than 80%. This is due principally to a block in activity of polypeptide chain initiation factor eIF-2. In this paper we show that there is impairment of the ability of the guanine nucleotide exchange factor (GEF) to displace GDP from eIF-2 X GDP complexes in extracts from cells incubated at the nonpermissive temperature. Addition of GEF or of high concentrations of eIF-2 stimulates protein synthesis to the level observed in control cell extracts, suggesting that GEF is rate-limiting for eIF-2 activity and overall protein synthesis at the nonpermissive temperature. Analysis of eIF-2 by two-dimensional gel electrophoresis and immunoblotting reveals an increase in the proportion of the alpha subunit in the phosphorylated form from 5.5 +/- 2.4% to 17.2 +/- 3.9% on shifting tsH1 cells from 34 to 39.5 degrees C. No such effect is seen in wild-type cells, which do not exhibit temperature-sensitive protein synthetic activity. Since the primary lesion in tsH1 cells is in their leucyl-tRNA synthetase, these results suggest a role for eIF-2 phosphorylation and GEF activity in coupling the rate of polypeptide chain initiation to the activity of the chain elongation machinery.


Subject(s)
Peptide Chain Initiation, Translational , Peptide Initiation Factors/metabolism , Proteins/metabolism , Animals , Carcinoma, Ehrlich Tumor/metabolism , Cell Line , Cricetinae , Cricetulus , Eukaryotic Initiation Factor-2 , Female , Guanine Nucleotide Exchange Factors , Leucine-tRNA Ligase/metabolism , Liver/metabolism , Mice , Ovary , Peptide Initiation Factors/isolation & purification , Phosphorylation , Proteins/isolation & purification , Temperature
7.
Eur J Nucl Med ; 4(4): 283-4, 1979 Aug 01.
Article in English | MEDLINE | ID: mdl-499248

ABSTRACT

The uptake of 201Tl-chloride in tumours has recently been investigated in several authors' laboratories. We are reporting studies on the uptake in malignant melanoma in mice. Generally, we confirm the published data qualitatively in finding higher uptake in tumour than in muscles. We confirm the rapid blood clearance and high kidney concentration, but we did not measure the myocardial uptake. We observed the concentrations in kidney muscle and tumour to rise during the first four hours while that in the liver fell from one hour onwards. We did not observe markedly higher uptake in melanin rich tumour than in other tumours.


Subject(s)
Citrates/metabolism , Melanoma/metabolism , Neoplasms, Experimental/metabolism , Radioisotopes/metabolism , Thallium/metabolism , Animals , Female , Kidney/metabolism , Melanins/metabolism , Mice , Mice, Inbred CBA , Tissue Distribution
8.
J Pathol ; 122(3): 117-27, 1977 Jul.
Article in English | MEDLINE | ID: mdl-407343

ABSTRACT

The drug p-hydroxyanisole (OHA) was found to inhibit the incorporation of 3H-thymidine in the Harding-Passey melanoma cells in culture. Because the cultured cells had lost some of their pigment-forming capacity, the enzyme tyrosinase was added to the culture. This greatly increased the sensitivity of the cells to OHA, strongly suggesting that cells producing the enzyme would be preferentially killed by the drug. An in-vivo study of the effect of OHA injected into tumour-bearing mice showed a beneficial effect, including increased survival time, reduction in tumour size and in many cases complete loss of tumour and no recurrence. An experiment with animals immunologically suppressed by radiation suggests that the effect is not an immunological one.


Subject(s)
Anisoles/therapeutic use , Melanoma/drug therapy , Animals , Anisoles/administration & dosage , Cells, Cultured , Cricetinae , DNA/metabolism , Drug Interactions , Melanoma/immunology , Mice , Mice, Inbred CBA , Monophenol Monooxygenase/therapeutic use , Neoplasms, Experimental/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...